NUTX Share Price Performance
US$87.01
41.33 (90.48%)
65.0% undervalued intrinsic discount
US$248.33
Fair Value
Price US$87.01
AnalystConsensusTarget US$248.33
AnalystLowTarget US$150.00
AnalystHighTarget US$300.00
Fair ValueUS$241.67
Share Pricen/a
Nutex Health Inc. Stock Price
- 4 Narratives written by author
- 1 Comments on narratives written by author
- 45 Fair Values set on narratives written by author
NUTX Community Narratives
AN
Fair Value US$241.67 64.0% undervalued intrinsic discount
Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AN
Fair Value US$150 42.0% undervalued intrinsic discount
No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value US$300 71.0% undervalued intrinsic discount
Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Nutex (NUTX) is undervalued
I believe earnings are forecast to increase. There is robust demand and robust earnings growth.Read more
2
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation
Key Takeaways Heavy reliance on out-of-network billing and arbitration exposes revenue to regulatory risks, payment delays, and shifting healthcare laws. Expansion into underserved markets and digital adoption support growth, but rising costs, competition, and evolving patient preferences threaten profitability and operational stability.Read more
135
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$150
42.0% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
3.95% p.a.
Profit Margin
18.3%
Future PE
8.17x
Price in 2029
US$107.42
Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks
Key Takeaways Accelerated revenue growth, margin expansion potential, and tech-driven efficiency position Nutex for outperformance amid industry shifts and upcoming regulatory changes. Strong patient satisfaction, local market gains, and capital strength support faster expansion, strategic acquisitions, and long-term earnings growth.Read more
30
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$300
71.0% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
25.55% p.a.
Profit Margin
0.81%
Future PE
182.99x
Price in 2028
US$307.9
Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks
Key Takeaways Demographic trends and consumer preference shifts are fueling expansion, with Nutex Health benefiting from micro-hospital growth and a rising share of ambulatory care. Strength in value-based care adoption, regulatory support, vertical integration, and tech-driven efficiencies positions the company for improving margins and sustainable earnings growth.Read more
525
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AN
US$241.67
64.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
22.66% p.a.
Profit Margin
8.58%
Future PE
14.96x
Price in 2028
US$247.78
Trending Discussion
Recently Updated Narratives
MS
Nutex (NUTX) is undervalued
Fair Value: US$165.64 47.5% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
NUTX: New Hospitals And Buybacks Will Support Future Margin Resilience
Fair Value: US$150 42.0% undervalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks
Fair Value: US$300 71.0% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nutex Health Inc. Key Details
About NUTX
- Founded
- 2011
- Employees
- 944
- CEO
- WebsiteView website
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
